1156 related articles for article (PubMed ID: 24119319)
1. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
Porst H; Gacci M; Büttner H; Henneges C; Boess F
Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
[TBL] [Abstract][Full Text] [Related]
2. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
Montorsi F; Brock G; Stolzenburg JU; Mulhall J; Moncada I; Patel HR; Chevallier D; Krajka K; Henneges C; Dickson R; Büttner H
Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081
[TBL] [Abstract][Full Text] [Related]
3. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale.
Rosen RC; Allen KR; Ni X; Araujo AB
Eur Urol; 2011 Nov; 60(5):1010-6. PubMed ID: 21855209
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
Porst H; Kim ED; Casabé AR; Mirone V; Secrest RJ; Xu L; Sundin DP; Viktrup L;
Eur Urol; 2011 Nov; 60(5):1105-13. PubMed ID: 21871706
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Porst H; Giuliano F; Glina S; Ralph D; Casabé AR; Elion-Mboussa A; Shen W; Whitaker JS
Eur Urol; 2006 Aug; 50(2):351-9. PubMed ID: 16766116
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.
Montorsi F; Aversa A; Moncada I; Perimenis P; Porst H; Barker C; Shane MA; Sorsaburu S
J Sex Med; 2011 Sep; 8(9):2617-24. PubMed ID: 21707928
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.
Guo YL; Zhu JC; Pan TM; Ding Q; Wang YX; Cheong NF; Lim E; Shen W; Venugopalan M; Chan M
Int J Urol; 2006 Jun; 13(6):721-7. PubMed ID: 16834650
[TBL] [Abstract][Full Text] [Related]
8. Impact of low testosterone on response to treatment with tadalafil 5 mg once daily for erectile dysfunction.
Goldfischer ER; Kim ED; Seftel AD; Baygani SK; Burns PR
Urology; 2014 Jun; 83(6):1326-33. PubMed ID: 24726311
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial.
Carrier S; Brock GB; Pommerville PJ; Shin J; Anglin G; Whitaker S; Beasley CM
J Sex Med; 2005 Sep; 2(5):685-98. PubMed ID: 16422827
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Zhao C; Kim SW; Yang DY; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Min KS; Park K; Park JK
Eur Urol; 2011 Aug; 60(2):380-7. PubMed ID: 21458153
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials.
Rosen RC; Shabsigh R; Kuritzky L; Wang WC; Sides GD
Curr Med Res Opin; 2005 Nov; 21(11):1701-9. PubMed ID: 16307689
[TBL] [Abstract][Full Text] [Related]
14. Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy.
Montorsi F; Oelke M; Henneges C; Brock G; Salonia A; d'Anzeo G; Rossi A; Mulhall JP; Büttner H
Eur Urol; 2016 Sep; 70(3):529-37. PubMed ID: 26947602
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of once-daily tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.
Shabsigh R; Seftel AD; Kim ED; Ni X; Burns PR
J Sex Med; 2013 Mar; 10(3):844-56. PubMed ID: 23035781
[TBL] [Abstract][Full Text] [Related]
16. Effects of 12 weeks of tadalafil treatment on ejaculatory and orgasmic dysfunction and sexual satisfaction in patients with mild to severe erectile dysfunction: integrated analysis of 17 placebo-controlled studies.
Paduch DA; Bolyakov A; Polzer PK; Watts SD
BJU Int; 2013 Feb; 111(2):334-43. PubMed ID: 23356749
[TBL] [Abstract][Full Text] [Related]
17. Durability of response following cessation of tadalafil taken once daily as treatment for erectile dysfunction.
Porst H; Glina S; Ralph D; Zeigler H; Wong DG; Woodward B
J Sex Med; 2010 Oct; 7(10):3487-94. PubMed ID: 20584129
[TBL] [Abstract][Full Text] [Related]
18. A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.
Kim ED; Seftel AD; Goldfischer ER; Ni X; Burns PR
J Sex Med; 2014 Mar; 11(3):820-30. PubMed ID: 23841532
[TBL] [Abstract][Full Text] [Related]
19. Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study.
Egerdie RB; Auerbach S; Roehrborn CG; Costa P; Garza MS; Esler AL; Wong DG; Secrest RJ
J Sex Med; 2012 Jan; 9(1):271-81. PubMed ID: 21981682
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of tadalafil in clinical populations.
Lewis RW; Sadovsky R; Eardley I; O'Leary M; Seftel A; Wang WC; Shen W; Walker DJ; Wong DG; Ahuja S
J Sex Med; 2005 Jul; 2(4):517-31. PubMed ID: 16422847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
